In recent years, data from the Cancer Genome Atlas and Genotype-Tissue Expression databases have shown that high CCT3 expression is associated with poor prognosis in LUAD patients.[76] Based on these findings, many researchers have explored the role of CCT3 in lung cancer. This evidence concerns the gene CCT3 and cancer.